The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Market Value Expansion Is Expected For The Orthobiologics Devices And Equipment Market Over The Forecast Period?
The orthobiologics devices and equipment market has shown robust growth in recent years. It is forecast to increase from $5.99 billion in 2025 to $6.36 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. This market’s historical expansion can be attributed to an uptick in musculoskeletal disorders, the widespread occurrence of sports injuries, the rise in orthopedic surgeries, the increasing adoption of PRP therapies, and the proven clinical effectiveness of bone grafts.
The orthobiologics devices and equipment market is projected to experience substantial expansion in the coming years. This market is forecast to reach $8.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.0%. This anticipated growth is driven by factors such as an expanding aging population, advancements in regenerative medicine, increased demand for minimally invasive treatments, broadening reimbursement policies, and innovations in biomaterials technology. Key trends anticipated during this period encompass a rise in the adoption of regenerative therapies, an increase in sports injury treatments, greater utilization of stem cell-based products, a growing preference for non-surgical orthopedic interventions, and the proliferation of orthopedic clinics.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2568&type=smp
Which Major Factors Are Contributing To The Development Of The Orthobiologics Devices And Equipment Market?
The rising prevalence of orthopedic disorders is projected to propel the expansion of the orthobiologics devices and equipment market in the future. Orthopedic disorders are defined as conditions affecting the musculoskeletal system, which includes bones, joints, muscles, ligaments, tendons, and nerves. The increasing demand for orthopedic treatments is attributed to the aging global population, as older individuals are more susceptible to musculoskeletal conditions such as osteoarthritis, osteoporosis, and fractures. Orthobiologics devices and equipment assist in managing orthopedic disorders by supporting natural tissue regeneration, thereby more effectively restoring bone and joint function. They improve treatment outcomes by enhancing healing efficiency and reducing recovery time for patients. For instance, in August 2023, a survey study by the Institute for Health Metrics and Evaluation, a US-based public health research institute, indicated that 15% of individuals aged 30 and older had osteoarthritis in 2023, and the number of affected individuals is expected to reach around 1 billion by 2050. Therefore, the growing occurrence of orthopedic disorders is a key driver for the orthobiologics devices and equipment market.
How Does Segment Analysis Break Down The Orthobiologics Devices And Equipment Market Structure?
The orthobiologics devices and equipment market covered in this report is segmented –
1) By Product Type: Demineralized Bone Matrix, Synthetic Bone Substitutes, Stem Cell Therapy, Plasma-Rich Protein, Viscosupplementation, Bone Morphogenetic Protein, Synthetic Orthobiologics
2) By Application: Osteoarthritis And Degenerative Arthritis, Soft-Tissue Injuries, Fracture Recovery, Maxillofacial And Dental Applications, Spinal Fusion, Trauma Repair, Reconstructive Surgery
3) By End Use: Hospitals, Orthopedic Clinics, Other End Users
Subsegments:
1) By Demineralized Bone Matrix: Injectable Demineralized Bone Matrix, Paste And Putty Forms, Demineralized Bone Matrix Scaffolds
2) By Synthetic Bone Substitutes: Calcium Phosphate Ceramics, Bioactive Glasses, Polymers And Composites
3) By Stem Cell Therapy: Adipose-Derived Stem Cell Products, Bone Marrow-Derived Stem Cell Products, Umbilical Cord Blood-Derived Stem Cell Products
4) By Plasma-Rich Protein: Platelet-Rich Plasma (PRP) Products, Platelet-Rich Fibrin (PRF) Products
5) By Viscosupplementation: Hyaluronic Acid Injections, Combination Viscosupplementation Products
6) By Bone Morphogenetic Protein (BMP): Recombinant Bone Morphogenetic Proteins, BMP Delivery Systems
7) By Synthetic Orthobiologics: Growth Factor-Enhanced Products, Biodegradable Scaffolds With Bioactive Agents, Other Synthetic Formulations
What Trends Are Driving Changes In The Orthobiologics Devices And Equipment Market?
Major companies within the orthobiologics devices and equipment market are concentrating on creating sophisticated regenerative technologies, such as synthetic bone fusion gels, to enhance surgical outcomes, accelerate healing, and minimize complications. Synthetic bone fusion gels are advanced biomaterial compositions that serve as both a scaffold and a delivery mechanism for growth factors, thereby encouraging bone development in spinal fusion and various orthopedic operations. For instance, in January 2024, Renovos Biologics Ltd., a UK-based biomaterial firm and investee of Biocomposites, obtained Food and Drug Administration (FDA) Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, Renovite BMP-2. This innovative, injectable, and moldable gel is engineered to localize and retain bone morphogenetic protein-2 (BMP-2) precisely at the surgical location. The objective of this technology is to facilitate effective bone healing while reducing the likelihood of ectopic bone formation and other soft-tissue issues linked with older carrier systems, thereby enabling a more regulated and efficient fusion process.
Who Are The Major Companies Operating In The Orthobiologics Devices And Equipment Market?
Major companies operating in the orthobiologics devices and equipment market are BONESUPPORT AB, Medtronic plc, Kuros Biosciences Ltd., Stryker Corporation, Baxter International Inc., DePuy Synthes, Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Arthrex Inc., Enovis Corp., Integra Lifesciences Holding Corporation, NuVasive Inc., Globus Medical Inc., Bioventus LLC, Orthofix Medical Inc., SeaSpine Holdings Corporation, Xtant Medical Holdings Inc., Acumed LLC, Bone Biologics Corp.
Access The Complete Orthobiologics Devices And Equipment Market Report:
Which Region Holds The Largest Share In The Orthobiologics Devices And Equipment Market?
North America was the largest region in the global Ortho biologics devices and equipment market in 2025. Western Europe was the second-largest region in the orthobiologics devices and equipment market report. The regions covered in the orthobiologics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Orthobiologics Devices And Equipment Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Orthobiologics Devices And Equipment Market 2026, By The Business Research Company
Orthopedic Braces And Support Devices And Equipment Market Report 2026
Orthopedic Accessories Market Report 2026
https://www.thebusinessresearchcompany.com/report/orthopedic-accessories-global-market-report
Orthopedic Biomaterials Market Report 2026
https://www.thebusinessresearchcompany.com/report/orthopedic-biomaterials-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model